Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment

Abstract

The authors measured levels of circulating angiogenic activators and examined their possible association with clinical and laboratory risk factors in chronic lymphocytic leukemia

Keywords

• angiogenesis
• chronic lymphocytic leukemia
• bFGF
• VEGF
• prognosis
• treatment
• fludarabine